Related Experiment Video
Updated: Dec 12, 2025
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
495
Tumor cryotherapy using Ice-producing bacteria
Mohammad Reza Atashzar1, Michael R Hamblin2, Farajolah Maleki3
1Department of Immunology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Medical Hypotheses
|August 8, 2020
Summary
This study explores using genetically modified anaerobic bacteria for cancer cryotherapy. By incorporating ice-producing genes, these bacteria could target tumors with low temperatures, potentially reducing side effects.
Area of Science:
- Oncology
- Microbiology
- Biotechnology
Background:
- Cryotherapy is a cancer treatment that uses low temperatures to destroy cancer cells.
- Low temperatures in cryotherapy can cause adverse side effects on surrounding healthy tissues.
- Bacterial-based cancer therapies offer a novel therapeutic strategy.
Discussion:
- This research investigates the potential of genetically engineering anaerobic bacteria to perform cancer cryotherapy.
- The study focuses on inserting the ice-nucleating (INA) gene from Pseudomonas syringe into anaerobic bacteria.
- The hypothesis is that these modified bacteria will migrate towards tumors and induce freezing via ice crystal formation.
Key Insights:
- The INA gene from Pseudomonas syringe possesses ice-producing properties.
- Anaerobic bacteria can be engineered to carry and express foreign genes.
- The proposed mechanism involves bacteria-mediated ice formation at the tumor site.
Outlook:
- Further research is needed to validate the efficacy and safety of this engineered bacterial cryotherapy.
- Investigating the precise migration patterns and ice-formation capabilities of the modified bacteria is crucial.
- This approach could lead to a more targeted and potentially less invasive cancer treatment method.
